A Dose-finding Study of Silodosin in Patients With Urinary Calculi
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
20 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients who have a unilateral ureteral calculus with ≥ 5 mm and ≤ 10 mm at Week 0.
Patients who are able to visit the site continually as out-patient during the study
Patients who have multiple urethral stones.
Patients who have or have history of a ureteral stricture or other structural passage obstruction of the ureter on affected side.
Patients who have been diagnosed with myasthenia gravis, myopathy, spina bifida, spinal cord injury, or fibromyalgia syndrome.
Patients who have a clinically significant hepatic or renal disorder.
Patients with postural hypotension or with a history of postural hypotension.
Patients with a history of sever drug allergy, or patients with a history of hypersensitivity to silodosin.
Patients who are pregnant, nursing, or desire pregnancy during the study period, or patients who cannot strictly comply with a physician's contraception directions.